旧药物,新挑战:为癌症治疗重新分配药物
Paulina Czechowicz1, Anna Więch-Walów1, Jakub Sławski1
1Department of Biophysics, Faculty of Biotechnology, University of Wroclaw, F. Joliot-Curie 14a Street, 50-383, Wroclaw, Poland.
Cellular & molecular biology letters
|March 4, 2025
概括
药物再利用为新的癌症疗法提供了更快,更具成本效益的策略. 这种方法利用现有的药物来克服新药开发中的挑战,并改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 药物发现 药物发现 药物发现
背景情况:
- 1971年开始的"抗癌战争"取得了进展,但在治疗复杂的瘤疾病方面仍然存在重大挑战.
- 目前的抗瘤疗法面临着安全问题,原因是异于目标效应,FDA批准的新药的开发成本越来越高,而且不那么成功.
- 开发新型癌症药物的高成本和有限的成功率需要采用替代方法.
研究的目的:
- 审查重新定位药物的历史和潜力,作为癌症治疗的替代策略.
- 讨论在瘤学中重新使用药物的成功和失败.
- 为了确定挑战和障碍,以提高重定向药物的潜力,用于新的癌症治疗.
主要方法:
- 对癌症治疗中重用药物历史数据的文献综述.
- 分析详细介绍药物重用成功和失败的案例研究.
- 讨论在瘤学中重新设计药物开发的当前障碍和未来方向.
主要成果:
- 药物再利用提供了一个更快,更具成本效益的替代方案,而不是开发新的癌症药物.
- 重用药物的既定安全性概况提供了一个优势,尽管组合疗法的相互作用需要彻底调查.
- 尽管面临挑战,重用药物在解决癌症治疗中未得到满足的需求方面具有重大前景.
结论:
- 重新利用现有药物是一种可行且有前途的策略,可以加速开发新的癌症疗法.
- 解决与组合疗法和监管途径相关的挑战对于最大限度地发挥重定向药物的潜力至关重要.
- 需要进一步的研究和战略实施,才能充分认识到在瘤学中药物重定向的好处.
更多相关视频
08:57Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
Published on: October 5, 2017
10.9K
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
7.1K
相关概念视频
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
02:56Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
01:17Drug Nomenclature
1.6K
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
1.6K
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
130
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
130
01:27Tumor Immunotherapy
461
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
461